Michael Castagna

Michael Castagna

Director Ejecutivo en MANNKIND CORPORATION .

Fortuna: 10 M $ al 30/06/2026

49 años
Health Technology
Consumer Services
Process Industries

Perfil

Michael E.
Castagna
is Chief Executive Officer & Director at MannKind Corp.
since 2017, President, Chief Executive Officer & Director at scPharmaceuticals, Inc. starting in 2025, and Director at Pet Partners.
Former roles include Executive Director-Immunology Franchise at Bristol Myers Squibb Co. from 2010 to 2012, Director at Pharmasset, Inc. from 2005 to 2006, Vice President-Global Commercial at Amgen, Inc. from 2012 to 2016, Vice President & Head-Biopharmaceuticals at Sandoz, Inc. from 2009 to 2010, and VP & Head-North America Biopharmaceuticals at Novartis AG.
Education includes a doctorate from Massachusetts College of Pharmacy & Health Science in 2014, an MBA from The Wharton School of the University of Pennsylvania in 2005, and an undergraduate degree from Philadelphia College of Pharmacy in 2000.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
15/07/2026 2.433.779 ( 0,79 % ) 10 M $ 30/06/2026

Cargos activos de Michael Castagna

EmpresasCargoInicio
MANNKIND CORPORATION Director Ejecutivo 25/05/2017
SCPHARMACEUTICALS INC. Director Ejecutivo 07/10/2025
Director/Miembro de la Junta -

Antiguos cargos conocidos de Michael Castagna.

EmpresasCargoFin
AMGEN INC. Corporate Officer/Principal 14/03/2016
BRISTOL-MYERS SQUIBB COMPANY Corporate Officer/Principal 01/11/2012
Corporate Officer/Principal 01/11/2010
Director/Miembro de la Junta -
NOVARTIS AG Corporate Officer/Principal -
Ver el detalle de la experiencia de Michael Castagna.

Formación de Michael Castagna.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

98

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Process Industries

  1. Bolsa de valores
  2. Insiders
  3. Michael Castagna